Starton Therapeutics to Present at Upcoming MedInvest and Needham Conferences
PARAMUS, N.J., -Starton Therapeutics Inc., (“Starton” or the “Company”), a clinical-stage biotechnology company focused on transforming standard-of-care therapies with proprietary continuous delivery technology, today announced that Pedro Lichtinger, Chairman…